Form S-1/A Elevation Oncology, Inc.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/16/2026
- S&P 500 ends higher as traders shift from AI to healthcare
- U.S. producer prices rise by 1.3% month-on-month in September
- Brent steady as US weighs easing sanctions on global 'shadow fleet'
- UBS now expects a third Fed rate hike after hot September inflation print
- Tesla-SpaceX Merger could be announced before December, Barclays says
- Vertiv shares fall on analyst downgrades and options bets
- Rocket Lab USA (RKLB) Reiterated at Overweight by Cantor Fitzgerald as Neutron Launch Moved to Next Year
- S&P 500 ends higher as traders shift from AI to healthcare
- Caterpillar names Derrick York to lead Resource Industries
- Most Asian stocks rise as calm returns after CoreWeave shock; Indonesia faces market downgrade
Elevation Oncology (ELEV) Files 6.25M Share IPO at $15-$17/sh
June 23, 2021 3:42 PM EDTElevation Oncology (NASDAQ: ELEV) has filed to IPO 6.25M shares at $15-$17 per share.
ELEV is a precision oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically-defined patient populations. It is focused on identifying... More



